Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 3011 Records) |
Query Trace: Ovarian cancer[original query] |
---|
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. Molecular cancer 2024 8 23 (1): 158. Ksenija Nesic, John J Krais, Yifan Wang, Cassandra J Vandenberg, Pooja Patel, Kathy Q Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S Penington, Franziska Geissler, Elizabeth Kyran, Robert Betsch, Lijun Xu, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Iain McNeish, Gayanie Ratnayake, Nadia Traficante, , Anna DeFazio, David D L Bowtell, Thomas C Harding, Kevin Lin, Elizabeth M Swisher, Olga Kondrashova, Clare L Scott, Neil Johnson, Matthew J Wakefie |
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene. Genetics in medicine : official journal of the American College of Medical Genetics 2024 8 101230. Robert D Morgan, George J Burghel, Nicola Flaum, Helene Schlecht, Andrew R Clamp, Jurjees Hasan, Claire Mitchell, Zena Salih, Sarah Moon, Martin Hogg, Rosemary Lord, Claire Forde, Fiona Lalloo, Emma R Woodward, Emma J Crosbie, Stephen S Taylor, Gordon C Jayson, D Gareth R Eva |
Causal relationship between gut microbiota and gynecological tumor: a two-sample Mendelian randomization study. Frontiers in microbiology 2024 8 15 1417904. Yajun Xiong, Xiaonan Zhang, Xiaoya Niu, Long Zhang, Yanbing Sheng, Aiguo |
Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report. Gynecologic oncology 2024 8 190 104-112. Erik Škof, Vida Stegel, Vita Šetraj?i? Dragoš, Ana Blatnik, Brigita Gregori?, Petra Škerl, Gašper Klan?ar, Anja Zagožen Klasinc, Alenka Bomba?, Mateja Krajc, Srdjan Novakov |
The Role of hBRCA2 in the Repair of Spontaneous and UV DNA Damage in Saccharomyces cerevisiae. microPublication biology 2024 8 2024 . Sherrice Law, David Park, Hannah Park, Hannah Zhang, Damon Mey |
Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancer. Frontiers in molecular biosciences 2024 8 11 1426274. Weiwei Gong, Mingqin Kuang, Hongxi Chen, Yiheng Luo, Keli You, Bin Zhang, Yueyang L |
Investigation of Polymorphisms in Global Genome Repair Genes in Patients With Ovarian Cancer in the Turkish Population. Cancer control : journal of the Moffitt Cancer Center 2024 8 31 10732748241270597. Sara Yaser Barham, Dorcas Omotade, Seda Y?lmaz, Fatma Tuba Akdeniz, Betül Çapar Goral?, Rukset Attar, Turgay ?sb |
Marginal Contribution of Pathogenic RAD51D Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients. Journal of cancer & allied specialties 2024 8 10 (2): 617. Noor Muhammad, Muhammad Sohail Afzal, Ute Hamann, Muhammad Usman Rash |
A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer. Cancer medicine 2024 8 13 (16): e70103. Jana Soukupova, Barbora Stastna, Madiha Kanwal, Jan Hojny, Petra Zemankova, Marianna Borecka, Leona Cerna, Marta Cerna, Monika Cerna, Vaclava Curtisova, Tatana Dolezalova, Petra Duskova, Lenka Foretova, Ondrej Havranek, Klara Horackova, Milena Hovhannisyan, Lucie Hruskova, Stepan Chvojka, Marketa Janatova, Maria Janikova, Sandra Jelinkova, Pavel Just, Marta Kalousova, Petra Kleiblova, Marcela Kosarova, Monika Koudova, Jan Kral, Michaela Krausova, Vera Krutilkova, Eva Machackova, Katerina Matejkova, Renata Michalovska, Petr Nehasil, Barbora Nemcova, Jan Novotny, Matous Palek, Pavel Pesek, Marketa Safarikova, Ondrej Scheinost, Drahomira Springer, Lenka Stolarova, Viktor Stranecky, Ivan Subrt, Spiros Tavandzis, Eva Tureckova, Kamila Vesela, Zdenka Vlckova, Michal Vocka, Tomas Zima, Libor Macurek, Zdenek Kleibl, |
Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods. Pathology oncology research : POR 2024 8 30 1611813. László Baráti, Anita Maász, Alexandra Mikó, Éva Bércesi, Sultan Al Kalbani, Judit Bene, Sebestyén Kovács, László Mangel, Kinga Hadzsi |
Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer. BMC cancer 2024 8 24 (1): 1000. Yasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Tazuko Inoue, Fumie Fujisawa, Kazuyoshi Ohka |
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? Frontiers in oncology 2024 7 14 1414343. Daniele Fanale, Lidia Rita Corsini, Chiara Brando, Ugo Randazzo, Marco Bono, Erika Pedone, Alessandro Perez, Roberta Sciacchitano, Daniela Cancelliere, Paola Piraino, Ambra Giurintano, Tancredi Didier Bazan Russo, Pietro Ferraro, Gaetana Rinaldi, Valeria Spinnato, Vincenzo Gennusa, Gianfranco Pernice, Salvatore Vieni, Gianni Pantuso, Antonio Russo, Viviana Baz |
Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer? Molecular diagnosis & therapy 2024 7 . Yi Liu, Xiaojun Chen, Huaiwu Lu, Xin Wu, Xuehan Liu, Fei Xu, Dongdong Ye, Bo Ding, Xiaoyan Lu, Ling Qiu, Jing Zhu, Yingying Wang, Xinya Huang, Zhen Shen, Tao Zhu, Yang Shen, Ying Zh |
Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8 TILs based on BRCA1/2 mutation status in epithelial ovarian cancers. Journal for immunotherapy of cancer 2024 7 12 (7): . Junsik Park, Jung Chul Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Eui-Cheol Shin, Jung Yun Lee, Su-Hyung Pa |
Urinary-based detection of MSL, HE4 and CA125 as an additional dimension for predictive and prognostic modelling in ovarian cancer. Frontiers in oncology 2024 7 14 1392545. Franziska Maria Schwarz, Daniel Martin Klotz, Pauline Wimberger, Jan Dominik Kuhlma |
Gynecologic Cancer InterGroup CA125 response has a high negative predictive value for CHK1 inhibitor RECIST response in recurrent ovarian cancer. Scientific reports 2024 7 14 (1): 17459. Kristen R Ibanez, Duncan Donohue, Tyler Malys, Jung-Min L |
Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2024 7 . Huimei Zhou, Qian Liu, Depu Zhang, Qingshui Li, Dongyan Cao, Ninghai Cheng, Xirun Wan, Ying Zhang, Fengzhi Feng, Yang Xiang, Jiaxin Ya |
The Clinical Significance of CRNDE Gene Methylation, Polymorphisms, and CRNDEP Micropeptide Expression in Ovarian Tumors. International journal of molecular sciences 2024 7 25 (14): . Laura Aleksandra Szafron, Roksana Iwanicka-Nowicka, Agnieszka Podgorska, Arkadiusz M Bonna, Piotr Sobiczewski, Jolanta Kupryjanczyk, Lukasz Michal Szafr |
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes 2024 7 15 (7): . Stefania Stella, Silvia Rita Vitale, Michele Massimino, Federica Martorana, Irene Tornabene, Cristina Tomarchio, Melissa Drago, Giuliana Pavone, Cristina Gorgone, Chiara Barone, Sebastiano Bianca, Livia Manzel |
Sexual Function in Women Diagnosed with Hereditary Breast and Ovarian Cancer Syndrome. Cancers 2024 7 16 (14): . Federico Ferrari, Juri Amonti, Andrea Giannini, Hooman Soleymani Majd, Valentina Zizioli, Giancarlo Tisi, Luigi Della Corte, Emma Bonetti, Elisa Gozzini, Franco Odici |
Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers 2024 7 16 (14): . Ava Kwong, Cecilia Y S Ho, Chun-Hang Au, Edmond S K |
[The efficacy and safety of anlotinib combined with niraparib in treating patients with platinum-resistant recurrent ovarian cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 7 46 (7): 696-702. M Yang, J J Wang, S Q Deng, S S Liang, L S |
Performance evaluation of predictive models for detecting MMR gene mutations associated with Lynch syndrome in cancer patients in a Chinese cohort in Taiwan. International journal of cancer 2024 7 . Fei-Hung Hung, Hung-Pin Peng, Chen-Fang Hung, Ling-Ling Hsieh, An-Suei Yang, Yong Alison Wa |
Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma. Cancer science 2024 7 . Kazuchika Nishitsuji, Remi Mito, Midori Ikezaki, Hiromu Yano, Yukio Fujiwara, Eri Matsubara, Taro Nishikawa, Yoshito Ihara, Kenji Uchimura, Naoyuki Iwahashi, Takuro Sakagami, Makoto Suzuki, Yoshihiro Komoha |
The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation. Journal of gynecologic oncology 2024 7 . Yeon Jee Lee, Ji Hyun Kim, Youn Jee Kim, Yoon Jung Chang, Sun-Young Kong, Chong Woo Yoo, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol L |
Association of tumor immune infiltration and prognosis with homologous recombination repair genes mutations in early triple-negative breast cancer. Frontiers in immunology 2024 7 15 1407837. Zheng Wang, Anqi Li, Yujie Lu, Mengyuan Han, Miao Ruan, Chaofu Wang, Xiaotian Zhang, Changbin Zhu, Kunwei Shen, Lei Dong, Xiaosong Ch |
Causal effect analysis of estrogen receptor associated breast cancer and clear cell ovarian cancer. American journal of translational research 2024 7 16 (6): 2699-2710. Li Ji, Yanbo Liu, Zihan Wang, Qiuru Huang, Jiaying Cai, Han Gu, Jiaxin Li, Xia Chen, Chenrui Feng, Xuxin He, Xiaonan Deng, Xinmeng Cheng, Xiuwen Kong, Xiaoqi Zhu, Tong Wu, Binbin Yang, Ziwen Lin, Xiaoqing Yang, Guannan Feng, Jun |
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands. Breast cancer (Tokyo, Japan) 2024 7 . Reiko Yoshida, Tomoko Kaneyasu, Arisa Ueki, Hideko Yamauchi, Shozo Ohsumi, Shinji Ohno, Daisuke Aoki, Shinichi Baba, Junko Kawano, Naomichi Matsumoto, Masao Nagasaki, Takayuki Ueno, Hitoshi Inari, Yusuke Kobayashi, Junko Takei, Osamu Gotoh, Mitsuyo Nishi, Miki Okamura, Keika Kaneko, Megumi Okawa, Misato Suzuki, Sayuri Amino, Mayuko Inuzuka, Tetsuo Noda, Seiichi Mori, Seigo Nakamu |
A comprehensive analysis of germline predisposition to early-onset ovarian cancer. Scientific reports 2024 7 14 (1): 16183. Klara Horackova, Petra Zemankova, Petr Nehasil, Michal Vocka, Milena Hovhannisyan, Katerina Matejkova, Marketa Janatova, Marta Cerna, Petra Kleiblova, Sandra Jelinkova, Barbora Stastna, Pavel Just, Tatana Dolezalova, Barbora Nemcova, Marketa Urbanova, Monika Koudova, Jana Hazova, Eva Machackova, Lenka Foretova, Viktor Stranecky, Michal Zikan, Zdenek Kleibl, Jana Soukupo |
Association between cholelithiasis, cholecystectomy, and risk of breast and gynecological cancers: Evidence from meta-analysis and Mendelian randomization study. Annals of human genetics 2024 7 . Jing Peng, Lianghua Li, Huai Ning, Xiaocheng |
- Page last reviewed:Feb 1, 2024
- Content source: